◼ Archived
Business
FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease
FDA approves Ultragenyx's gene therapy Fayuvi for Sanfilippo syndrome at a price of $3.95 million.
Fayuvi
1 trends tracked about this subject — the full history, oldest to newest below.